BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 9636173)

  • 1. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
    Razi N; Varki A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
    Powell LD; Varki A
    J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
    Sgroi D; Nocks A; Stamenkovic I
    J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.
    Zhang M; Varki A
    Glycobiology; 2004 Nov; 14(11):939-49. PubMed ID: 15240561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
    Hanasaki K; Powell LD; Varki A
    J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition.
    Powell LD; Sgroi D; Sjoberg ER; Stamenkovic I; Varki A
    J Biol Chem; 1993 Apr; 268(10):7019-27. PubMed ID: 8463235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.
    Sjoberg ER; Powell LD; Klein A; Varki A
    J Cell Biol; 1994 Jul; 126(2):549-62. PubMed ID: 8034751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.
    Nitschke L; Floyd H; Ferguson DJ; Crocker PR
    J Exp Med; 1999 May; 189(9):1513-8. PubMed ID: 10224292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin.
    Sgroi D; Varki A; Braesch-Andersen S; Stamenkovic I
    J Biol Chem; 1993 Apr; 268(10):7011-8. PubMed ID: 8463234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.
    Danzer CP; Collins BE; Blixt O; Paulson JC; Nitschke L
    Int Immunol; 2003 Oct; 15(10):1137-47. PubMed ID: 13679384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
    Hanasaki K; Varki A; Powell LD
    J Biol Chem; 1995 Mar; 270(13):7533-42. PubMed ID: 7706300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding.
    Powell LD; Jain RK; Matta KL; Sabesan S; Varki A
    J Biol Chem; 1995 Mar; 270(13):7523-32. PubMed ID: 7706299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion.
    Braesch-Andersen S; Stamenkovic I
    J Biol Chem; 1994 Apr; 269(16):11783-6. PubMed ID: 8163475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
    Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
    J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.
    Jin L; McLean PA; Neel BG; Wortis HH
    J Exp Med; 2002 May; 195(9):1199-205. PubMed ID: 11994425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
    Engel P; Wagner N; Miller AS; Tedder TF
    J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
    Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
    Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
    Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22.
    van der Merwe PA; Crocker PR; Vinson M; Barclay AN; Schauer R; Kelm S
    J Biol Chem; 1996 Apr; 271(16):9273-80. PubMed ID: 8621588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.